Cargando…
Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma
Lipid remodeling regulators are now being investigated as potential therapeutic targets for cancer therapy as a result of their involvement, which includes promoting cancer cells’ adaptation to the restricted environment. Lysophosphatidylcholine acyltransferases (LPCATs, LPCAT1-4) are enzymes that r...
Autores principales: | Lu, Yaoyong, Liang, Hongfeng, Li, Xiaoyin, Chen, Haiwen, Yang, Changfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292872/ https://www.ncbi.nlm.nih.gov/pubmed/37294538 http://dx.doi.org/10.18632/aging.204723 |
Ejemplares similares
-
Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021) -
Mitochondrial Reactive Oxygen Species Formation Determines ACSL4/LPCAT2-Mediated Ferroptosis
por: Merkel, Melanie, et al.
Publicado: (2023) -
LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021) -
LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma
por: Zhang, Hongbin, et al.
Publicado: (2020) -
LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
por: Li, Lan, et al.
Publicado: (2022)